Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Other Non-Current Assets for 5 consecutive years, with $34.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 2.02% year-over-year to $34.6 million, compared with a TTM value of $34.6 million through Dec 2025, up 2.02%, and an annual FY2025 reading of $32.9 million, down 77.47% over the prior year.
  • Other Non-Current Assets was $34.6 million for Q4 2025 at Roivant Sciences, up from $27.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $145.9 million in Q1 2024 and bottomed at $8.9 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $35.5 million, with a median of $32.8 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets surged 416.99% in 2023, then tumbled 77.47% in 2025.
  • Year by year, Other Non-Current Assets stood at $20.9 million in 2021, then skyrocketed by 121.43% to $46.2 million in 2022, then rose by 1.35% to $46.8 million in 2023, then fell by 27.68% to $33.9 million in 2024, then grew by 2.02% to $34.6 million in 2025.
  • Business Quant data shows Other Non-Current Assets for ROIV at $34.6 million in Q4 2025, $27.8 million in Q3 2025, and $31.1 million in Q2 2025.